Fresenius Medical Care AG & Co. KGaA (FMCQF)
USD 46.12
(-2.91%)
USD 46.12
(-2.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.93 Billion EUR | -7.51% |
| 2022 | 3.41 Billion EUR | -8.73% |
| 2021 | 3.54 Billion EUR | -12.32% |
| 2020 | 4.13 Billion EUR | 12.08% |
| 2019 | 3.92 Billion EUR | 35.37% |
| 2018 | 2.9 Billion EUR | -6.34% |
| 2017 | 3 Billion EUR | 7.38% |
| 2016 | 3.03 Billion EUR | -0.28% |
| 2015 | 2.8 Billion EUR | 22.22% |
| 2014 | 2.49 Billion EUR | 17.56% |
| 2013 | 2.13 Billion EUR | -0.7% |
| 2012 | 2.13 Billion EUR | 4.21% |
| 2011 | 2.05 Billion EUR | 11.34% |
| 2010 | 1.84 Billion EUR | 18.26% |
| 2009 | 1.55 Billion EUR | 2.73% |
| 2008 | 1.51 Billion EUR | 13.87% |
| 2007 | 1.33 Billion EUR | 10.88% |
| 2006 | 1.2 Billion EUR | 19.61% |
| 2005 | 1 Billion EUR | 25.58% |
| 2004 | 800.33 Million EUR | 3.5% |
| 2003 | 773.23 Million EUR | -10.39% |
| 2002 | 862.93 Million EUR | -20.09% |
| 2001 | 789.79 Million EUR | 7.49% |
| 2000 | 1 Billion EUR | -30.06% |
| 1999 | 839.17 Million EUR | 91.35% |
| 1998 | 654.81 Million EUR | -74.65% |
| 1997 | 2.96 Billion EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 736.45 Million EUR | 27.89% |
| 2024 Q1 | 729 Million EUR | -25.62% |
| 2023 Q3 | 883.93 Million USD | 1.43% |
| 2023 Q1 | 840.22 Million USD | -4.95% |
| 2023 Q2 | 871.48 Million USD | 3.72% |
| 2023 Q4 | 954.66 Million EUR | 8.0% |
| 2023 FY | - EUR | -7.51% |
| 2022 FY | - EUR | -8.73% |
| 2022 Q4 | 884.02 Million EUR | 11.43% |
| 2022 Q3 | 793.31 Million EUR | 5.96% |
| 2022 Q2 | 748.68 Million EUR | -0.99% |
| 2022 Q1 | 756.13 Million EUR | -19.71% |
| 2021 Q1 | 981.02 Million EUR | -7.39% |
| 2021 Q4 | 941.77 Million EUR | 6.24% |
| 2021 Q3 | 886.45 Million EUR | 11.18% |
| 2021 Q2 | 797.33 Million EUR | -18.72% |
| 2021 FY | - EUR | -12.32% |
| 2020 Q1 | 940.23 Million EUR | -10.53% |
| 2020 Q3 | 1.02 Billion EUR | -3.03% |
| 2020 Q4 | 1.05 Billion EUR | 2.94% |
| 2020 FY | - EUR | 12.08% |
| 2020 Q2 | 1.06 Billion EUR | 12.87% |
| 2019 FY | - EUR | 35.37% |
| 2019 Q3 | 1.02 Billion EUR | 14.06% |
| 2019 Q4 | 1.05 Billion EUR | 2.73% |
| 2019 Q2 | 896.85 Million EUR | -3.24% |
| 2019 Q1 | 926.87 Million EUR | -1.64% |
| 2018 Q4 | 942.31 Million EUR | 33.53% |
| 2018 Q1 | 696 Million EUR | -1.85% |
| 2018 Q2 | 748.17 Million EUR | 7.5% |
| 2018 Q3 | 705.69 Million EUR | -5.68% |
| 2018 FY | - EUR | -6.34% |
| 2017 Q3 | 798.74 Million EUR | 3.83% |
| 2017 FY | - EUR | 7.38% |
| 2017 Q1 | 869.87 Million EUR | -20.58% |
| 2017 Q2 | 769.3 Million EUR | -11.56% |
| 2017 Q4 | 709.08 Million EUR | -11.22% |
| 2016 FY | - EUR | -0.28% |
| 2016 Q3 | 778.29 Million EUR | 1.13% |
| 2016 Q1 | 646.9 Million EUR | -25.09% |
| 2016 Q4 | 1.09 Billion EUR | 40.73% |
| 2016 Q2 | 769.62 Million EUR | 18.97% |
| 2015 Q1 | 683.51 Million EUR | -15.33% |
| 2015 FY | - EUR | 22.22% |
| 2015 Q4 | 863.57 Million EUR | 21.66% |
| 2015 Q3 | 709.84 Million EUR | 8.35% |
| 2015 Q2 | 655.14 Million EUR | -4.15% |
| 2014 Q3 | 633.12 Million EUR | 16.85% |
| 2014 FY | - EUR | 17.56% |
| 2014 Q4 | 807.26 Million EUR | 27.51% |
| 2014 Q2 | 541.85 Million EUR | 18.77% |
| 2014 Q1 | 456.23 Million EUR | -20.69% |
| 2013 Q4 | 575.24 Million EUR | 8.12% |
| 2013 FY | - EUR | -0.7% |
| 2013 Q3 | 532.05 Million EUR | -1.04% |
| 2013 Q2 | 537.64 Million EUR | 4.45% |
| 2013 Q1 | 514.74 Million EUR | 1.66% |
| 2012 Q2 | 577.41 Million EUR | 18.17% |
| 2012 Q4 | 506.33 Million EUR | -9.39% |
| 2012 Q3 | 558.79 Million EUR | -3.22% |
| 2012 Q1 | 488.63 Million EUR | -23.36% |
| 2012 FY | - EUR | 4.21% |
| 2011 Q1 | 413.55 Million EUR | -23.83% |
| 2011 Q4 | 637.6 Million EUR | 23.19% |
| 2011 Q2 | 448.35 Million EUR | 8.41% |
| 2011 Q3 | 517.55 Million EUR | 15.43% |
| 2011 FY | - EUR | 11.34% |
| 2010 FY | - EUR | 18.26% |
| 2010 Q1 | 412.5 Million EUR | -9.52% |
| 2010 Q4 | 542.9 Million EUR | 24.8% |
| 2010 Q3 | 435.03 Million EUR | -12.43% |
| 2010 Q2 | 496.77 Million EUR | 20.43% |
| 2009 Q2 | 377.64 Million EUR | -0.9% |
| 2009 Q1 | 381.08 Million EUR | -9.43% |
| 2009 FY | - EUR | 2.73% |
| 2009 Q4 | 455.91 Million EUR | 18.2% |
| 2009 Q3 | 385.7 Million EUR | 2.13% |
| 2008 Q2 | 337.82 Million EUR | 9.94% |
| 2008 FY | - EUR | 13.87% |
| 2008 Q1 | 307.28 Million EUR | -10.48% |
| 2008 Q3 | 390.65 Million EUR | 15.64% |
| 2008 Q4 | 420.78 Million EUR | 7.71% |
| 2007 Q4 | 343.24 Million EUR | 2.72% |
| 2007 Q2 | 351.28 Million EUR | 4.38% |
| 2007 FY | - EUR | 10.88% |
| 2007 Q1 | 336.55 Million EUR | 12.34% |
| 2007 Q3 | 334.15 Million EUR | -4.88% |
| 2006 Q1 | 251.5 Million EUR | -8.53% |
| 2006 Q4 | 299.57 Million EUR | -11.16% |
| 2006 Q3 | 337.2 Million EUR | 5.01% |
| 2006 FY | - EUR | 19.61% |
| 2006 Q2 | 321.11 Million EUR | 27.68% |
| 2005 FY | - EUR | 25.58% |
| 2005 Q4 | 274.95 Million EUR | 10.37% |
| 2005 Q1 | 215.76 Million EUR | 34.88% |
| 2005 Q3 | 249.11 Million EUR | -0.67% |
| 2005 Q2 | 250.8 Million EUR | 16.24% |
| 2004 Q2 | 221.54 Million EUR | 7.03% |
| 2004 FY | - EUR | 3.5% |
| 2004 Q4 | 159.97 Million EUR | -26.15% |
| 2004 Q1 | 206.99 Million EUR | 25.26% |
| 2004 Q3 | 216.62 Million EUR | -2.22% |
| 2003 Q1 | 202.88 Million EUR | 10.52% |
| 2003 Q3 | 214.18 Million EUR | 5.68% |
| 2003 FY | - EUR | -10.39% |
| 2003 Q4 | 165.25 Million EUR | -22.85% |
| 2003 Q2 | 202.66 Million EUR | -0.11% |
| 2002 FY | - EUR | -20.09% |
| 2002 Q3 | 225.01 Million EUR | 2.9% |
| 2002 Q2 | 218.67 Million EUR | -15.26% |
| 2002 Q1 | 258.05 Million EUR | 2728.74% |
| 2002 Q4 | 183.57 Million EUR | -18.42% |
| 2001 Q4 | -9.81 Million EUR | -103.84% |
| 2001 Q2 | 293.93 Million EUR | 8.79% |
| 2001 FY | - EUR | 7.49% |
| 2001 Q1 | 182.79 Million EUR | 37.58% |
| 2001 Q3 | 255.45 Million EUR | -13.09% |
| 2000 Q1 | 226.05 Million EUR | 110.58% |
| 2000 Q4 | 196.37 Million EUR | -54.93% |
| 2000 Q3 | 435.72 Million EUR | 167.67% |
| 2000 Q2 | 162.78 Million EUR | -27.99% |
| 2000 FY | - EUR | -30.06% |
| 1999 Q3 | 897.96 Million EUR | -3.17% |
| 1999 FY | - EUR | 91.35% |
| 1999 Q2 | 927.36 Million EUR | 3.98% |
| 1999 Q1 | 891.88 Million EUR | 150.23% |
| 1999 Q4 | -2.13 Billion EUR | -338.0% |
| 1998 Q4 | -1.77 Billion EUR | -335.05% |
| 1998 Q1 | 819.87 Million EUR | 1.07% |
| 1998 Q3 | 755.45 Million EUR | -4.93% |
| 1998 FY | - EUR | -74.65% |
| 1998 Q2 | 794.62 Million EUR | -3.08% |
| 1997 Q2 | 702.26 Million EUR | 2.99% |
| 1997 FY | - EUR | 0.0% |
| 1997 Q4 | 811.18 Million EUR | 12.16% |
| 1997 Q3 | 723.21 Million EUR | 2.98% |
| 1997 Q1 | 681.89 Million EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 26811.496% |
| Arem Pacific Corporation | 36.71 Thousand USD | -7990797.453% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | 2598481.026% |
| BioCorRx Inc. | -2.68 Million USD | 109412.342% |
| Bionik Laboratories Corp. | -4.77 Million USD | 61532.892% |
| Banyan Corp. | 583.94 Thousand USD | -502322.843% |
| Clearday, Inc. | -7.53 Million USD | 39029.253% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | -22790686.918% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | 269686.935% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 132866.432% |
| Selectis Health, Inc. | -7.29 Million USD | 40321.688% |
| Ethema Health Corporation | 2.07 Million USD | -141483.71% |
| HealthLynked Corp. | -2.75 Million USD | 106773.914% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 110628.646% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | -10170661.977% |
| Comjoyful International Company | 167.89 Thousand USD | -1747336.195% |
| Medical Facilities Corporation | 77.94 Million USD | -3664.011% |
| MedSmart Group Inc. | 47.8 Thousand USD | -6136522.812% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | 470774.923% |
| Nova Leap Health Corp. | 994.46 Thousand USD | -294918.729% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | 1454448.882% |
| PAO Group, Inc. | 292.96 Thousand USD | -1001343.186% |
| Primemd Inc. | 3.42 Million USD | -85511.545% |
| Raffles Medical Group Ltd | 100.7 Million USD | -2813.459% |
| Ryman Healthcare Limited | -54.51 Million USD | 5481.506% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 69309289.7% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 101468.577% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | 528240.599% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 5987565.306% |
| Veltex Corporation | -938.45 Thousand USD | 312725.725% |
| World Financial Holding Group | -28.43 Thousand USD | 10319684.945% |
| Xcelerate Inc. | -2.53 Million USD | 115681.576% |